Lifevantage Corporation (LFVN)
Nasdaq: LFVN · Pharmaceutical Preparations · Lehi, UT · filing with the SEC since 1996
Grade5.8
◀ Past 6.6● Present 6.2▶ Future 4.6
Filings
235 filings since 2017 beside 429 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Dec 31, 2026Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by Feb 9, 2027
10-K
Annual report for the fiscal year ending Jun 30, 2027Accelerated filers have 75 days after the fiscal year ends.
by Sep 13, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Sep 18, 2026.
Filings a yearinsider forms included
53895449109737558
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Aug 3, 2026.SEC letters: 2 in the last 36 months, the newest Mar 18, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Feb 4, 2026
8-K items 2.02, 5.02, 9.01
Results released; Officer or director change · Current report
Jan 30, 2026
40 of 235 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.